NCT04125160View on ClinicalTrials.gov

Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

September 3, 2020

Study Completion Date

September 3, 2020

Conditions
HbA1cPeritoneal DiseasesGlycated AlbuminFructosamineContinuous Glucose Monitoring
Interventions
DEVICE

Continuous glucose monitoring

Continuous glucose monitoring over 16 days

DIAGNOSTIC_TEST

Glycaemic markers

Measurement of HbA1c, glycated albumin and fructosamine.

Trial Locations (5)

2100

Herlev Hospital, Copenhagen

Rigshospitalet department of nephrology, København Ø

3400

Hillerød Hospital, Hillerød

Unknown

Rigshospitalet department of endocrinology, Copenhagen

Roskilde Hospital, Roskilde

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Hillerod Hospital, Denmark

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT04125160 - Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter